HTG Molecular Diagnostics, Inc. Operating Lease, Expense
HTG Molecular Diagnostics, Inc. reported Operating Lease, Expense of $134.60 thousand for the 3-month period ending 2021-09-30, per its 10-Q filed 2021-11-10.
Discontinued › Expense Statement › Operating Expenses
us-gaap:OperatingLeaseExpense · last filed 2021-11-10
- HTG Molecular Diagnostics, Inc. operating lease, expense for the quarter ending 2021-09-30 was $134.60K, a 38.49% decline year-over-year.
- HTG Molecular Diagnostics, Inc. operating lease, expense for the quarter ending 2021-06-30 was $128.36K, a 43.29% decline year-over-year.
- HTG Molecular Diagnostics, Inc. operating lease, expense for the quarter ending 2021-03-31 was $193.83K, a 9.71% decline year-over-year.
- HTG Molecular Diagnostics, Inc. operating lease, expense for the quarter ending 2020-12-31 was $218.33K, a 3.00% decline year-over-year.
- HTG Molecular Diagnostics, Inc. operating lease, expense for fiscal 2020 was $878.21K, a 17.12% increase from fiscal 2019.
- HTG Molecular Diagnostics, Inc. operating lease, expense for fiscal 2019 was $749.85K.
| Period end | Operating Lease, Expense 3 month | Operating Lease, Expense 6 month | Operating Lease, Expense 9 month | Operating Lease, Expense 12 month |
|---|---|---|---|---|
| 2021-09-30 | $134.60K 10-Q · filed 2021-11-10 | $262.96K derived: sum of 2 quarters · filed 2021-11-10 | $456.79K 10-Q · filed 2021-11-10 | $675.12K derived: sum of 4 quarters · filed 2021-11-10 |
| 2021-06-30 | $128.36K 10-Q · filed 2021-08-12 | $322.19K 10-Q · filed 2021-08-12 | $540.51K derived: sum of 3 quarters · filed 2021-08-12 | $759.35K derived: sum of 4 quarters · filed 2021-11-10 |
| 2021-03-31 | $193.83K 10-Q · filed 2021-05-13 | $412.16K derived: sum of 2 quarters · filed 2021-05-13 | $631.00K derived: sum of 3 quarters · filed 2021-11-10 | $857.35K derived: sum of 4 quarters · filed 2021-11-10 |
| 2020-12-31 | $218.33K derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-25 | $437.17K derived: sum of 2 quarters · filed 2021-11-10 | $663.52K derived: sum of 3 quarters · filed 2021-11-10 | $878.21K 10-K · filed 2021-03-25 |
| 2020-09-30 | $218.84K 10-Q · filed 2021-11-10 | $445.20K derived: sum of 2 quarters · filed 2021-11-10 | $659.88K 10-Q · filed 2021-11-10 | $884.95K derived: sum of 4 quarters · filed 2021-11-10 |
| 2020-06-30 | $226.35K 10-Q · filed 2021-08-12 | $441.04K 10-Q · filed 2021-08-12 | $666.11K derived: sum of 3 quarters · filed 2021-08-12 | $876.90K derived: sum of 4 quarters · filed 2021-08-12 |
| 2020-03-31 | $214.68K 10-Q · filed 2021-05-13 | $439.75K derived: sum of 2 quarters · filed 2021-05-13 | $650.54K derived: sum of 3 quarters · filed 2021-05-13 | $846.90K derived: sum of 4 quarters · filed 2021-05-13 |
| 2019-12-31 | $225.07K derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-25 | $435.86K derived: sum of 2 quarters · filed 2021-03-25 | $632.22K derived: sum of 3 quarters · filed 2021-03-25 | $749.85K 10-K · filed 2021-03-25 |
| 2019-09-30 | $210.79K 10-Q · filed 2020-11-10 | $407.15K derived: sum of 2 quarters · filed 2020-11-10 | $524.78K 10-Q · filed 2020-11-10 | |
| 2019-06-30 | $196.36K 10-Q · filed 2020-08-11 | $313.99K 10-Q · filed 2020-08-11 | ||
| 2019-03-31 | $117.63K 10-Q · filed 2020-05-13 |